Both medications have been shown to induce weight loss by decreasing hunger, slowing gastric emptying, and promoting a feeling of fullness
As the buzz around GLP-1 medications grew to a fever pitch over the past two years, many digital health and telehealth companies quickly added programs to prescribe anti-obesity drugs
Semaglutide, as a GLP-1 receptor agonist, mimics and amplifies the effects of this natural hormone
Pre-existing conditions like diabetes, heart problems, or immune disorders can slow healing and increase the risk of complications
Mild dehydration can be misinterpreted as hunger, and adequate fluid intake (approximately 2 litres daily for most adults, though needs vary with activity level, climate, and individual factors) supports the medication's action and helps manage potential side effects such as constipation
Its important to note that while peptides are not FDA-approved, they have been used in research and clinical settings with excellent results